Stille & Vascular Access Centers partner to develop and enable safer treatments of vascular diseases

June 22, 2012 - PRLog -- Peripheral arterial disease (PAD) affects nearly 10 million Americans.  In the last decade, X-ray guided endovascular repair has emerged as the gold standard treatment of PAD replacing open surgery.  A challenge in endovascular repair is to follow guidelines and minimize the X-ray radiation exposure to patients and clinicians.

The Vascular Access Centers (VAC) and Stille have partnered with the goal of developing new state-of-the-art clinical solutions that enable improved patient care, reduced X-ray dosing and potential for higher patient capacity.

VAC was founded in 2005 by Dr. James F. McGuckin with a vision of providing enhanced patient care through clinical excellence and unparalleled service.  Seven years later, VAC’s rapidly expanding clinics are equipped with state-of-the-art infrastructure enabling treatment of PAD by some of the nation’s leaders in vascular surgery.  The majority of the clinics are equipped with Stille’s imaging tables.

“The versatility and the free floating function of Stille’s tables have enabled us to grow with more cost-effective and safer procedures,” comments James McGuckin, MD and CEO of VAC.

In April 2012, Stille introduced imagiQ2, the second generation of vascular surgery tables based on new innovations aiming to reduce X-ray dose, improve imaging quality and enable more efficient endovascular repair.

As part of the partnership, VAC and Stille intend to conduct clinical studies to confirm the benefits of combining leading technology with surgical perfection.  The goal is to enable new dimensions in the treatment of vascular diseases.

“VAC is an impressive clinical organization and the partnership aims to jointly achieve new industry standards in improved endovascular repair with reduced radiation dose for physicians and patients,” comments Philip Siberg, CEO of Stille AB.

For more info, please contact:

Phillip Siberg            
CEO Stille AB            
+46 70 790 6734         

James F. McGuckin, M.D.
Vascular Access Centers
215-382-2680